Latest Insider Transactions at Moderna, Inc. (MRNA)
This section provides a real-time view of insider transactions for Moderna, Inc. (MRNA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Moderna, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Moderna, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 11
2018
|
Afeyan Noubar |
BUY
Conversion of derivative security
|
Indirect |
47,343,020
+26.74%
|
-
|
|
Dec 11
2018
|
Stephen Berenson Director |
BUY
Conversion of derivative security
|
Direct |
22,798
+50.0%
|
-
|
|
Dec 11
2018
|
Israel Ruiz Director |
BUY
Conversion of derivative security
|
Direct |
4,559
+50.0%
|
-
|
|
Dec 11
2018
|
Paul Sagan Director |
BUY
Conversion of derivative security
|
Indirect |
367,776
+50.0%
|
-
|
|
Dec 11
2018
|
Robert Langer Director |
BUY
Conversion of derivative security
|
Direct |
4,559
+0.04%
|
-
|
|
Dec 11
2018
|
Elizabeth G Nabel Director |
BUY
Conversion of derivative security
|
Direct |
13,679
+23.58%
|
-
|
|
Dec 11
2018
|
Stephen Hoge President |
BUY
Conversion of derivative security
|
Direct |
458
+0.02%
|
-
|